Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

CBD: What is it? A former DEA agent explains.

Dennis Wichern
Meds
April 4, 2019
259 Shares
Share
Tweet
Share

What is CBD?

Cannabidiol or CBD for short is made from either the marijuana plant that contains tetrahydrocannabinol (THC) or hemp which contains little to any THC. “Hemp-derived” means that the CBD generally contains less than 0.3% THC while “marijuana-derived” contains higher amounts of THC. It is THC — and not CBD — is the primary psychoactive or intoxicating component of marijuana. CBD can also be manufactured synthetically.

CBD is routinely sold as an oil extract commonly referred to as CBD oil.

Overall, CBD is used by consumers as an over-the-counter alternative medicine to self-treat a variety of ills such as acne, addiction, anxiety or stress, chronic pain, depression, epilepsy, glaucoma, insomnia, loss of appetite, muscle spasms, Parkinson’s disease and more. Additionally, it is used as an additive in some food and beauty products to address the above conditions and also used in some forms to treat certain animal conditions.

What’s the FDA’s view?

This past June, the FDA approved the first-ever CBD drug, Epidiolex, a Schedule V medication to help treat two rare forms of epilepsy, Dravet syndrome and Lennox-Gestaut syndrome in patients two years of age and older. Epidiolex contains less than 0.15% THC with a list price around $32,500 annually, however, its insurance costs are significantly lower.

On June 25, 2018, FDA Commissioner Scott Gottlieb M.D. released a statement citing the agency’s approval of Epidiolex by stating: “This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies. Controlled clinical trials testing the safety and efficacy of a drug, along with careful review through the FDA’s drug approval process, is the most appropriate way to bring marijuana-derived treatments to patients.”

In the same statement, Dr. Gottlieb cautioned that the FDA is also “prepared to take action when we see the illegal marketing of CBD-containing products with serious, unproven medical claims. Marketing unapproved products, with uncertain dosages and formulations, can keep patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.”

What about the CDC?

According to the CDC, “Cannabis-based products, such as man-made cannabinoid-based medications, may help prevent and ease nausea caused by chemotherapy.” Short-term use has been shown to help adults with multiple sclerosis-related muscle spasms.

Regarding its use for chronic pain, the CDC finds that uncertainty remains about its effectiveness and that “more information is needed to know if pain relief from cannabis is any better or worse than other pain management options, such as over over-the-counter drugs like ibuprofen or alternative treatments like occupational therapy.”

How about the DEA?

When Epidiolex was approved in 2018, DEA concluded its press announcement on September 27, 2018 with the following statement: “Marijuana and CBD derived from marijuana remain against the law, except for the limited circumstances that it has been determined there is a medically approved benefit. In those instances, such as here, the drug will be made appropriately available to the public for medical use. ”

The DEA’s view of CBD is that the drug is illegal due to the definition of “marihuana” found in Title 21 United States Code §802 (16). Two things to keep in mind, the Controlled Substances Act (“CSA”) was made law in 1970 and has changed little in almost 50 years and secondly, with the DEA’s focus on cartels, gangs, fentanyl and the opioid crisis, CBD oils and products may likely never be on DEA’s radar due to the agency’s limited resources.

Is it legal?

It depends.

The federal Agriculture Improvement Act of 2018 that was signed into law on December 20, 2018, removed hemp or low content THC cannabis from the Controlled Substances Act, which means that it is no longer an illegal substance under federal law. The same act defined hemp as cannabis that contained less than 0.3% of THC but made no mention of CBD.

CBD is currently legal in 30 states that have legalized marijuana use and 17 other states that have legalized some type of CBD.

Standard dosage unit?

There are currently no established standards for safely producing CBD oil or a standard dosage unit. As a 2017 published JAMA study found, “Among CBD products purchased online, a wide range of CBD concentrations was found, consistent with the lack of an accepted dose. Of tested products, 26% contained less CBD than labeled, which could negate any potential clinical response.”

“The over labeling of CBD products in this study is similar in magnitude to levels that triggered warning letters to 14 businesses in 2015-2016 from the US Food and Drug Administration, suggesting that there is a continual need for federal and state regulatory agencies to take steps to ensure label accuracy of these consumer products.”

Last thoughts

CBD oil derived from hemp (marijuana with a THC content of less than 0.3% as defined federally) looks promising as a medicine especially as evidenced by the FDA’s recent approval of Epidiolex.

Medical professionals considering utilizing CBD oil should review the latest scientific studies and ensure that their preferred product is manufactured to the highest standards, legal in their state and the exact contents of the drugs are known.

Dennis Wichern is a retired DEA agent.

Image credit: Shutterstock.com

Prev

It is time for physicians to reclaim the power of touch

April 4, 2019 Kevin 3
…
Next

When did people’s feelings start mattering more than patient safety?

April 4, 2019 Kevin 14
…

Tagged as: Medications, Oncology/Hematology

Post navigation

< Previous Post
It is time for physicians to reclaim the power of touch
Next Post >
When did people’s feelings start mattering more than patient safety?

More by Dennis Wichern

  • Telemedicine should be easy. Here’s why it’s not.

    Dennis Wichern
  • How to avoid negative press and fines during the opioid crisis

    Dennis Wichern
  • Kratom: harmless herbal supplement or dangerous drug?

    Dennis Wichern

Related Posts

  • A DEA agent explains how to fight the opioid crisis and mitigate DEA risk

    Dennis Wichern
  • 5 hidden consequences of chronic pain

    Toni Bernhard, JD
  • 5 things I wish I had known earlier about chronic pain

    Tom Bowen
  • Using low-dose naltrexone to treat pain

    Alex Smith
  • Blame the pain, not the opioids

    Angelika Byczkowski
  • On the internet, you are looking for something to make you angry

    Judson Ellis

More in Meds

  • 13.1 million missing Americans since 1980. Where’s the outrage?

    Steve Burgess, MD
  • Ketamine for mental health conditions: What every primary care physician needs to know

    Carlene MacMillan, MD & L. Alison McInnes, MD
  • Learn to be a Narcan hero: a comic tutorial

    Emily Watters, MD
  • The preference for insurance coverage of opioids over non-pharmaceutical options explained

    Amy Baxter, MD
  • A comic reveals the terrifying truth about fentanyl

    Emily Watters, MD
  • The importance of physician education regarding psilocybin therapy

    Lynn Marie Morski, MD, JD
  • Most Popular

  • Past Week

    • Ethical considerations in medicine: unity and open discourse

      Andrew Zywiec, MD | Physician
    • Unveiling excessive medical billing and greed

      Amol Saxena, DPM, MPH | Policy
    • I’m a doctor, and I almost died during childbirth

      Bayo Curry-Winchell, MD | Physician
    • For newer doctors, avoid lifestyle inflation

      Amarish Dave, DO | Finance
    • Family support is pivotal in the treatment of schizophrenia

      Frank Chen, MD | Conditions
    • Chronic health issues and homelessness

      Michele Luckenbaugh | Policy
  • Past 6 Months

    • Medical gaslighting: a growing challenge in today’s medical landscape

      Tami Burdick | Conditions
    • Balancing opioid medication in chronic pain

      L. Joseph Parker, MD | Conditions
    • I want to be a doctor who can provide care for women: What states must I rule out for my medical education?

      Nandini Erodula | Education
    • Navigating the broken medical system: challenges faced by foreign medical graduates

      Anonymous | Physician
    • The essence of medicine: genuine connections in practice

      Jennifer Tillman, MD | Physician
    • 1 in 4 attempt suicide: the persecution of autistic physicians

      Patricia Celan, MD | Physician
  • Recent Posts

    • Family support is pivotal in the treatment of schizophrenia

      Frank Chen, MD | Conditions
    • Is emergency medicine your calling? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Exploring disfigurement and self-worth

      Kathleen Watt | Conditions
    • AI is living up to its promise as a tool for radiology

      Hoag Memorial Hospital Presbyterian | Tech
    • The shifting landscape of gastroenterology manpower and compensation

      Brian Hudes, MD | Physician
    • I’m tired of being a distracted doctor

      Shiv Rao, MD | Tech

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 2 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Loneliness Needs to Be Treated Like Any Other Health Condition, Researcher Suggests
  • 'Con Man' Gets Another Top Hospital Job, This Time at Penn Medicine
  • TikTok Dinged for Misinformation; BRCA Risk Overestimated; Cheers for Oncology
  • Flawed Rules in No Surprises Act Hurt Doctors and Patients, Experts Say
  • IG Live September 25: When the Healers Need Healing

Meeting Coverage

  • Loneliness Needs to Be Treated Like Any Other Health Condition, Researcher Suggests
  • Stopping Medical Misinformation Requires Early Detection
  • AI Has an Image Problem in Healthcare, Expert Says
  • Want Better Health Outcomes? Check Out What Other Countries Do
  • ERS Roundup: Cell Transplant Boosts Lung Function in COPD Patients
  • Most Popular

  • Past Week

    • Ethical considerations in medicine: unity and open discourse

      Andrew Zywiec, MD | Physician
    • Unveiling excessive medical billing and greed

      Amol Saxena, DPM, MPH | Policy
    • I’m a doctor, and I almost died during childbirth

      Bayo Curry-Winchell, MD | Physician
    • For newer doctors, avoid lifestyle inflation

      Amarish Dave, DO | Finance
    • Family support is pivotal in the treatment of schizophrenia

      Frank Chen, MD | Conditions
    • Chronic health issues and homelessness

      Michele Luckenbaugh | Policy
  • Past 6 Months

    • Medical gaslighting: a growing challenge in today’s medical landscape

      Tami Burdick | Conditions
    • Balancing opioid medication in chronic pain

      L. Joseph Parker, MD | Conditions
    • I want to be a doctor who can provide care for women: What states must I rule out for my medical education?

      Nandini Erodula | Education
    • Navigating the broken medical system: challenges faced by foreign medical graduates

      Anonymous | Physician
    • The essence of medicine: genuine connections in practice

      Jennifer Tillman, MD | Physician
    • 1 in 4 attempt suicide: the persecution of autistic physicians

      Patricia Celan, MD | Physician
  • Recent Posts

    • Family support is pivotal in the treatment of schizophrenia

      Frank Chen, MD | Conditions
    • Is emergency medicine your calling? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Exploring disfigurement and self-worth

      Kathleen Watt | Conditions
    • AI is living up to its promise as a tool for radiology

      Hoag Memorial Hospital Presbyterian | Tech
    • The shifting landscape of gastroenterology manpower and compensation

      Brian Hudes, MD | Physician
    • I’m tired of being a distracted doctor

      Shiv Rao, MD | Tech

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

CBD: What is it? A former DEA agent explains.
2 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...